Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Congress Holds Select Agent Laboratory Hearing
In October of 2007, the Subcommittee on Oversight and Investigations, part of the Committee on Energy and Commerce, held a hearing on government oversight of select agent laboratories. Testimony given by Dr. Richard Besser, director of an agency at the federal Centers for Disease Control and Prevention, detailed needed improvements to the inspection, documentation, and verification processes at the laboratories.
Colorado State University Opens Regional Biocontainment Laboratory
Colorado State University celebrated the opening of its $30 million Regional Biocontainment Laboratory on October 2, 2007. Sited on the Foothills Campus in Fort Collins, the 38,000-sf aerosol challenge facility will house mice for infectious disease and potential bioterror agent research. The BSL-3 laboratory features a $600,000 mass spectrometer, autoclaves, seven-layer epoxy floors, and rigorous HEPA air filtration. The project was built by a joint venture of Heath Construction with Hensel Phelps Construction.
Colorado State Constructs Bioenvironmental Research Building Phase III
Colorado State University has selected Heath Construction to build the $6.75 million third phase of Colorado State University's Bioenvironmental Research Building. The 21,700-sf, three-story addition to the existing Bioenvironmental Research Building is scheduled for completion in late 2008. The expansion will house research programs on infectious diseases and an array of mechanical and technical systems.
George Mason Breaks Ground on Biocontainment Laboratory
George Mason University broke ground on Sept. 25, 2007 on its Biomedical Research Laboratory on the Prince William campus in Manassas, Va. The $42 million facility is one of 13 Regional Biocontainment Laboratories (RBL) and was funded in part by a $25 million grant from the National Institutes of Health. The 53,000-sf facility will house BSL-3 laboratories for biological threat and infectious disease research and will be operated by the National Center for Biodefense and Infectious Diseases (NCBID) at George Mason University.
University of Pittsburgh Opens Regional Biocontainment Laboratory
The University of Pittsburgh opened the $28 million Center for Vaccine Research (CVR) in late September of 2007. Located on the eighth and ninth floors of the 330,000-sf Biomedical Science Tower 3, the CVR is comprised of two facilities, the NIAID-funded Regional Biocontainment Laboratory (RBL) and the Vaccine Research Laboratory (VRL). The 27,300-sf RBL contains BSL-3 laboratories for infectious disease research.